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Abstract
Luteal cells express class II major histocompatibility complex (MHC) molecules and can stimulate T lymphocyte proliferation
in vitro. However, it is unknown whether luteal cells express the intracellular components necessary to process the peptides
presented by class II MHC molecules. The objective of the present study was to examine the expression and regulation of
three major class II-associated antigen processing components – class II MHC-associated invariant chain (Ii), DMa and DMb
– in luteal tissue. Corpora lutea were collected early in the estrous cycle, during midcycle and late in the estrous cycle, and at
various times following administration of a luteolytic dose of prostaglandin F2a (PGF2a) to the cow. Northern analysis revealed
the presence of mRNA encoding each of the class II MHC-associated antigen processing proteins in luteal tissue. Ii mRNA
concentrations did not change during the estrous cycle, whereas DMa and DMb mRNA concentrations were highest in
midcycle luteal tissue compared with either early or late luteal tissue. Tumor necrosis factor-a (TNF-a) reduced DMa mRNA
concentrations in cultured luteal cells in the presence of LH or PGF2a. DMa and DMb mRNA were also present in highly
enriched cultures of luteal endothelial (CLENDO) cells, and DMa mRNA concentrations were greater in CLENDO cultures
compared with mixed luteal cell cultures. Expression of invariant chain, DMa and DMb genes indicates that cells within the
corpus luteum express the minimal requirements to act as functional antigen-presenting cells, and the observation that
CLENDO cells are a source of DMa and DMb mRNA indicates that non-immune cells within the corpus luteum may function
as antigen-presenting cells.
Reproduction (2006) 131 689–698

Introduction
Luteal regression is a complex cascade of events, initiated
by prostaglandin F2a (PGF2a), that causes cessation of
luteal function and subsequent structural demise of the
corpus luteum (CL). Several lines of evidence suggest participation of the immune system in this process. Macrophages and T lymphocytes are present in the CL of several
species, and infiltrate the CL near the time of luteal
regression and in response to PGF2a (Bagavandoss et al.
1990, Brännström et al. 1994, Lawler et al. 1999, Penny
et al. 1999, Krusche et al. 2002, Townson et al. 2002,
Komatsu et al. 2003, Neuvians et al. 2004). Cytokines
produced by these cells – including tumor necrosis
factor (TNF)-a, interferon (IFN)-g, interleukin (IL)-1b and

IL-6 – decrease progesterone production, increase prostaglandin synthesis and stimulate apoptotic death in cultured luteal cells (Nothnick & Pate 1990, Fairchild & Pate
1991, Benyo & Pate 1992, Gorospe et al. 1992, Townson
& Pate 1994, 1996, Jo et al. 1995, Del Vecchio &
Sutherland 1997, Young et al. 1997, Petroff et al. 2001).
The presence of these cytokines has been detected in
luteal tissue (Bagavandoss et al. 1990, Ji et al. 1991,
Penny et al. 1999, Petroff et al. 1999, Krusche et al. 2002,
Townson et al. 2002, Komatsu et al. 2003, Neuvians et al.
2004), indicating that macrophages and T cells present
within the CL are activated. Class II major histocompatibility complex (MHC) molecules are also expressed by
luteal cells of several species (Khoury & Marshall 1990,
Benyo et al. 1991, Kenny et al. 1991, Penny et al. 1999),
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providing a means of activation of T lymphocytes present
in luteal tissue.
Class II MHC molecules, which are typically expressed
on antigen-presenting cells of the immune system (i.e.
macrophages, dendritic cells and B lymphocytes), present
small peptides processed intracellularly to T lymphocytes
(Sant 1994). When cells expressing class II MHC molecules (antigen-presenting cells) interact with T cells, the
peptides bound to the MHC molecules determine whether
the antigen-presenting cell will activate T cells. The
immune system is tolerant of normally expressed self-peptides, but T lymphocytes can be activated by cells expressing peptides derived from a foreign source (i.e. viral or
bacterial peptides) as well as self-peptides that are presented by MHC molecules under abnormal conditions
(i.e. tumor antigens). As class II MHC molecules are synthesized, they immediately bind to a chaperone protein
called invariant chain (Ii), a portion of which occupies the
peptide-binding groove of the MHC molecule (Roche &
Cresswell 1990, Avva & Cresswell 1994). Invariant chain
serves a dual function, directing intracellular transport of
class II MHC molecules (Bakke & Dobberstein 1990, Lotteau et al. 1990) and ensuring that binding of ‘inappropriate’ peptides does not occur prematurely (Roche &
Cresswell 1990). Class II MHC–Ii complexes are transported into specialized intracellular compartments in
which proteases degrade the Ii into a peptide called class
II-associated invariant chain peptide (CLIP) (Maric et al.
1994, Riese et al. 1996). Prior to binding of antigenic peptides by class II MHC molecules, the CLIP fragment bound
to the peptide binding groove must be removed. Removal
of CLIP is carried out by a class II MHC-like heterodimeric
protein referred to as DM (Fling et al. 1994, Morris et al.
1994). Following CLIP removal, DM stabilizes class II
MHC molecules to allow efficient binding of antigenic
peptides (Denzin et al. 1996).
In addition to the primary roles for Ii and DM described
above, these intracellular proteins have been implicated
in a secondary role as ‘editors’ of the repertoire of peptides presented to T cells in the context of class II MHC,
since they control in part the type of peptides that bind to
class II MHC molecules and that are presented to T lymphocytes (Castellino et al. 1997, Vogt et al. 1999). Antigen-presenting cells taken from Ii or DM knockout
animals stimulate activation and proliferation of otherwise
non-reactive T cell clones and reveal the presence of
‘self-reactive’ T cells in normal animals (Bodmer et al.
1994, Katz et al. 1996, Marieke van Ham et al. 1996,
Lightstone et al. 1997), indicating that alterations in Ii or
DM expression may alter the ability of antigen-presenting
cells to stimulate T cell activation.
Expression of class II MHC molecules is not limited to
cells of the immune system, and in many cases expression
of class II MHC molecules by other cell types is associated
with inflammation and/or autoimmune disorders. Cells of
the bovine CL express class II MHC molecules, and class
II MHC expression increases near the end of the estrous
Reproduction (2006) 131 689–698

cycle and in response to a luteolytic dose of PGF2a
(Benyo et al. 1991). Bovine luteal cells also stimulate
class II MHC-dependent in vitro proliferation of T cells
isolated from the same animal (autologous T cells) (Petroff
et al. 1997). Following administration of a luteolytic dose
of PGF2a to the cow, the ability of luteal cells to stimulate
T lymphocyte proliferation is enhanced (Petroff et al.
1997). The enhancement of luteal cell-stimulated T lymphocyte proliferation may be due at least in part to the
effect of PGF2a on progesterone synthesis in vitro (Cannon
et al. 2003), which decreases following in vivo exposure
to PGF2a (Pate & Nephew 1988). However, we speculate
that changes in expression of class II MHC genes and
associated antigen-processing genes may also be involved
in the enhancement of luteal cell-stimulated T cell proliferation, and that processing of antigens by luteal cells
may be altered near the time of luteal regression. Alteration of antigen processing within luteal cells could result
in binding of a different repertoire of peptides to class II
MHC molecules, allowing luteal cells to stimulate T cell
activation during luteal regression. The hypothesis tested
in the present study is that expression of either Ii or DM
changes near the end of the estrous cycle. Due to observations in the initial portion of the present study, we
wished to determine whether steady-state concentrations
of DMa and DMb mRNA are regulated by luteinizing hormone (LH) and PGF2a, the classic hormonal regulators of
luteal function, or by TNF-a, which is suspected to play a
significant role in regulation of luteal function. We have
also examined highly enriched cultures of luteal endothelial (CLENDO) cells for the presence of DMa and DMb
mRNA, to determine whether endothelial cells of the CL
express the components of the class II MHC antigen-processing pathway.

Materials and Methods
Reagents
Powdered Ham’s F-12 culture medium, gentamicin, fetal
bovine serum, Escherichia coli DH5a chemically competent cells, and TRIzol Reagent were all purchased from
Life Technologies (Grand Island, NY, USA). Recombinant
murine TNF-a was purchased from Life Technologies and
R&D Systems (Minneapolis, MN, USA). The National Hormone and Pituitary Program (Baltimore, MD, USA) provided bovine LH (NIAMMD-bLH-4). Insulin-transferrinselenium (ITS) premix was obtained from BD Biosciences
(Bedford, MA, USA). Bovine serum albumin (fraction V),
PGF2a, HEPES buffer and Bouin’s fixative were purchased
from Sigma. Prefer fixative was purchased from Anatech
Ltd (Battle Creek, MI, USA). Type I collagenase was
acquired from Worthington Biochemical Corp. (Freehold,
NJ, USA). SDS and MOPS buffer were acquired from
Amresco (Solon, OH, USA). Digoxigenin-labeled rNTP
mix, alkaline-phosphatase-conjugated anti-digoxigenin Fab
fragments, CDP-Star chemiluminescent substrate, blocking
www.reproduction-online.org
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reagent, LightCycler-FastStart DNA SYBR Green I kits and
ampicillin were all purchased from Roche. Random hexamer primers were purchased from Amersham. SuperScript II reverse transcriptase was acquired from
Invitrogen. DyNAmo HS SYBR Green qPCR kits were
purchased from MJ Research (Boston, MA, USA). Restriction enzymes, RNA polymerases, dNTPs, recombinant
RNase inhibitor, Moloney murine leukemia virus
(M-MLV) reverse transcriptase, isopropyl-b-D -thiogalactopyranoside (IPTG) and 5-bromo-4-chloro-3-indolyl-b-D galactopyranoside (X-Gal) were purchased from Promega.
Hybond N þ membranes were obtained from Amersham
Pharmacia Biotech (Piscataway, NJ, USA). Tissue culture
flasks were from Corning (Acton, MA, USA). All other
chemicals were purchased from Sigma or Fisher Scientific
(Fairlawn, NJ, USA).
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Multiparous, lactating dairy cows between 3 and 6 years
of age were used in the present studies. Animals were
housed indoors and had complete freedom of movement;
they were given regular access to a total mixed ration and
were allowed to feed ad libitum. Corpora lutea were
removed transvaginally from regularly cycling dairy cows.
Blood samples were collected from all animals prior to CL
removal to determine circulating concentrations of progesterone. Corpora lutea were cut into four equal pieces,
three of which were immediately snap frozen in liquid
nitrogen, transported to the laboratory and stored at
280 8C until RNA extraction was performed. In the first
experiment, CL were removed early in the estrous cycle
(day 5, n ¼ 6), during midcycle (days 9 –12, n ¼ 6) or late
in the estrous cycle (day 18, n ¼ 6), or at 0.5 (n ¼ 5), 1
(n ¼ 5), 4 (n ¼ 5), 12 (n ¼ 4) or 24 h (n ¼ 5) following
i.m. administration of 25 mg PGF2a (Lutalyse; Upjohn Co.,
Kalamazoo, MI, USA). In the second experiment, CL were
removed during midcycle, immediately placed in ice-cold
Ham’s F-12 culture medium on ice and transported to the
laboratory for dissociation. Handling of animals and surgical procedures were carried out in accordance with protocols approved by the Institutional Laboratory Animal Care
and Use Committee of The Ohio State University.

Fifteen micrograms of total cellular RNA were electrophoretically separated on 1.5% agarose denaturing gels
containing 20 mM MOPS buffer, 5 mM sodium acetate,
1 mM EDTA and 0.66 M formaldehyde. Following electrophoresis, gels were stained for 15 min with 1 mg/ml ethidium bromide in DEPC-treated water, destained for 1 h in
DEPC-treated water and photographed. RNA was transferred to Hybond-N þ membranes, and membranes were
baked at 80 8C for 2 h to crosslink RNA to the membranes.
Gels were restained with eithidum bromide following
transfer and examined under u.v. light to confirm complete transfer of RNA.
Digoxigenin-labeled riboprobes were synthesized using
plasmids containing full-length Bovine Lymphocyte Antigen (BoLA)-DMa, BoLA-DMb or bovine class II MHCassociated Ii cDNA sequences. Plasmids containing these
sequences have been described previously (Niimi et al.
1995, 1996) and were provided by Dr Yoko Aida (The
Institute of Physical and Chemical Research, Tsukuba,
Japan). Digoxigenin-labeled riboprobes were generated
using linearized plasmids according to the instructions in
Roche Molecular Biochemicals’ DIG Nonradioactive
Nucleic Acid Labeling and Detection System manual.
Membranes were prehybridized at 68 8C for 1 h with
hybridization core buffer (250 mM sodium phosphate,
1 mM EDTA, 5% (w/v) SDS containing 0.5% (w/v) Roche
DIG Nucleic Acid Detection System Blocking Reagent),
and hybridization was carried out for 16 h at 68 8C. Following hybridization, membranes were washed and detection was performed using alkaline phophatase-conjugated
anti-digoxigenin Fab fragments in concert with the chemiluminescent CDP-Star substrate, according to the specifications in Roche Molecular Biochemical’s DIG
Nonradioactive Nucleic Acid Labeling and Detection System manual. Membranes were exposed to Biomax ML
film (Eastman Kodak Co., Rochester, NY, USA) to detect
chemiluminescence.
Quantification of steady-state concentrations of each
message was performed densitometrically using a PDI
420oe scanning densitometer. The densitometric value (in
arbitrary densitometric units) of the band of interest in
each sample was standardized to the densitometric values
of the corresponding 18S rRNA.

RNA isolation and Northern analysis

Luteal cell dissociation and culture

Frozen tissue collected for the first experiment was homogenized in TRIzol reagent using a Polytron tissue homogenizer (Brinkman Instruments, Westbury, NY, USA). In
the second experiment, RNA from cultured cells was isolated by adding TRIzol reagent directly to culture flasks.
Following tissue homogenization or cell lysis, total cellular RNA was isolated according to procedures outlined by
the manufacturer. The final RNA precipitate was resuspended in double-distilled water containing 0.1% diethyl
pyrocarbonate (DEPC) and RNA concentration was determined spectrophotometrically.

Dissociation of luteal cells was carried out according to
procedures described previously (Pate & Condon 1982).
Cell culture was performed in a humidified atmosphere of
5% CO2 in air at 37 8C. Dispersed luteal cells (4 £ 106
cells/flask) were cultured in Ham’s F-12 medium supplemented with insulin (5 mg/ml), transferrin (5 mg/ml), selenium (5 ng/ml), gentamicin (20 mg/ml) and LH (1 ng/ml)
in serum-coated 25 cm2 flasks, in a total of 4 ml of culture
medium. Cells were allowed to adhere overnight, medium
was replaced and cultures were treated with LH
(10 ng/ml), TNF-a (50 ng/ml) or PGF2a (10 ng/ml) in a

Animals and tissue collection
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3 £ 3 factorial arrangement. Treatment concentrations
used in this study have been shown previously to affect
function, viability and gene expression in cultured bovine
luteal cells (Pate & Condon 1984, Townson & Pate 1994,
Petroff et al. 2001, Cannon & Pate 2003). Medium and
treatments were replaced after 24 h. Total RNA was
extracted from cultured cells after 48 h of culture. The
experiment was replicated a total of four times using CL
from different animals.

Isolation and culture of purified luteal endothelial cells
Purified endothelial cells from bovine CL (CLENDO cells)
collected during early pregnancy were purchased from
Cambrex BioScience (BioWittaker, Walkersville, MD,
USA) as described previously (Cavicchio et al. 2002, Pru
et al. 2003, Liptak et al. 2005). In the present study, endothelial cells from frozen aliquots (passages 3 –5; 5000
cells/cm2) were cultured in EGM-2MV media, as recommended by the supplier with 3% fetal bovine serum
(Cambrex Bioscience) in 60 mm dishes. Cultures were
maintained at 37 8C in a humidified atmosphere of 5%
CO2 and 95% air. Culture medium was replaced every
48 h until 80 –90% confluent. On the day of harvest, cells
were equilibrated for 2 –3 h in serum-free EBM-2 medium.
CLENDO cells were collected in RLT lysis buffer and RNA
was isolated using the RNeasy kit (Qiagen, Valencia, CA,
USA) according to the manufacturer’s specifications.

Quantitative reverse transcription-PCR (RT-qPCR)
Primers used to amplify DMa and DMb cDNAs were
designed based on the published sequences for DMa and
DMb (Niimi et al. 1995; GenBank accession numbers
D76416 and D76417 respectively). Primer sequences
were 50 -GCTCTCTGAGTCCTACGACGA-30 and 50 -GCACAGCACATTCTCCAGAAG-30 for DMa forward and reverse
primers respectively, and 50 -CACCTGTGTGTTGGACGATGA-30 and 50 -AGCGTTACCAGAGCCACAGAA-30 for
DMb forward and reverse primers respectively. Amplification using DMa primers resulted in a single 526 bp DMa
cDNA fragment, whereas amplification using DMb primers resulted in a single 597 bp DMb cDNA fragment.
Primer sequences used for amplification of steroidogenic
acute regulatory protein (StAR) and CD31 (an endothelial
cell adhesion molecule) mRNA in cultures of mixed luteal
cells or luteal endothelial cells were based on the
published sequences (Hartung et al. 1995, GenBank
accession number NM_174189; Stewart et al. 1996,
GenBank accession number U35433) and were as
follows: 50 -CCTCTCTACAGCGACCAA-30 and 50 -TCGTGAGTGATGACCGTG-30 for StAR forward and reverse
primers respectively; 50 -GTTCAGCGAAGTTCTGCGAG-30
and 50 -CTTGCTGGCTGTGGTCTTGT-30 for CD31 forward
and reverse primers respectively. Amplification using the
CD31 primers resulted in a 229 bp CD31 cDNA product
and amplification using StAR primers yielded a 311 bp
StAR cDNA product. The identity of all PCR products was
Reproduction (2006) 131 689–698

confirmed by DNA sequence analysis. An 854 bp glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA fragment was amplified in parallel reactions, using ovine
specific primers described previously (Tsai et al. 1996),
and concentrations of DMa, DMb, CD31 and StAR in
each sample were standardized to the corresponding
G3PDH concentrations.
Steady-state concentrations of mRNA encoding StAR,
CD31, DMa and DMb were determined in total RNA
extracted from cultures of mixed luteal cells and luteal
endothelial cells, using an MJ Research Opticon 2 realtime PCR thermal cycler. Prior to PCR, reverse transcription using random hexamer primers was performed on
2 mg of total RNA extracted from cultures. PCR was then
performed, using 200 ng of reverse transcribed cDNA,
using the DyNAmo HS SYBR Green qPCR kit according to
the manufacturer’s instructions. Thermal cycling was carried out using the following conditions: denaturation,
94 8C for 30 s; annealing, 56 8C for 30 s; extension, 72 8C
for 60 s, for a total of 32 cycles. Melting curve analysis
was performed after the end of the last cycle and, in conjunction with gel electrophoresis of amplified products,
was used to verify the amplification of a single product in
each sample. Fluorescence values in each tube were
measured at the end of each cycle using single acquisition
mode. Fluorescence values of the product of interest in
each sample were standardized to the corresponding
G3PDH fluorescence values, and these standardized
values were then used to calculate the mean steady-state
amounts of each message. Since no standard curve was
run for the messages of interest, values were expressed in
arbitrary units of fluorescence for the purposes of analysis.
Steady-state concentrations of DMa and DMb mRNA
were determined in total RNA extracted from luteal cells
treated with LH, PGF2a and TNF-a using a Roche LightCycler real-time PCR thermal cycler. Prior to quantitative
PCR, DMa, DMb or G3PDH reverse primer was used to
reverse transcribe 200 ng of total cellular RNA extracted
from cultured cells. Quantitative PCR was then performed
on 40 ng of reverse transcribed RNA, using the Roche
LightCycler-FastStart DNA Master SYBR Green I kit
according to the manufacturer’s instructions. As a standard
curve, DMa, DMb and G3PDH cDNAs were amplified
from lymph node total RNA, electrophoretically separated
on a 1.2% agarose gel and eluted. The concentration of
purified cDNA products was determined spectrophotometrically, and serial dilutions were prepared and used as an
external standard curve in the quantitative PCR assays.
Thermal cycling was carried out using the following conditions: denaturation, 94 8C for 30 s; annealing, 58 8C for
30 s; extension, 72 8C for 60 s, 40 cycles total. The ramping speed for transition from denaturation to annealing
steps and annealing to extension steps was set manually at
18/s, while the ramping speed from extension to denaturation steps was set at 208/s to minimize total running time.
Melting curve analysis was performed after the end of the
last cycle in order to verify the amplification of a single
www.reproduction-online.org
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product in each sample. There was no evidence of primer
dimers or bands other than the desired amplicons in the
reactions as determined by melting curve analysis, and
this was confirmed by gel electrophoresis of amplified
products. The lack of undesired products allowed fluorescence measurements to be taken at the same temperature (72 8C) at which extension was performed.
Fluorescence values in each tube were measured at the
end of each cycle using single acquisition mode. Samples
were run in duplicate and fluorescence values for duplicate samples were averaged. The baseline fluorescence
reading and noise band cut-off were set manually for
samples and standards, in order to eliminate background
fluorescence values from calculation of the slope and
y-intercept of the standard curve. A standard curve was
generated using average fluorescence values of duplicate
standards. Average fluorescence values of samples were
then used to calculate the concentration of target cDNA
in each amplification reaction, using the Fit Points
methods of the accompanying LightCycler data analysis
software.

Statistical analysis
Normalized densitometric values collected from Northern
analyses in the first experiment were subjected to twoway analysis of variance to determine whether differences
in mean densitometric values of DMa, DMb, or Ii RNA
existed between stages of the estrous cycle. In the instance
of a significant F value, the Student– Newman–Kuels
(S–N–K) test was used to determine differences between
specific means. Relative differences in steady-state concentrations of CD31, StAR, DMa and DMb mRNA
between cultures of mixed luteal cells or luteal endothelial cells were determined using Student’s t test. In the
third experiment, steady-state concentrations of DMa or
DMb mRNA in treated luteal cell cultures were subjected
to one-way ANOVA to determine if differences existed
between treatment means. In the incidence of a significant
F value, the S– N–K test was used to determine differences
between specific treatment means. Differences were considered to be significant at P , 0.05. A P value between
0.05 and 0.08 was considered to show a tendency
towards a significant difference. All statistical procedures
were performed using the SigmaStat statistical analysis
software package (Jandel Corporation, San Rafael, CA,
USA).

Results
The results of the Northern analyses to detect and quantify
Ii, DMa and DMb mRNA in luteal tissue are displayed in
Figs 1 to 3. Figure 1A demonstrates the presence of an Ii
transcript of approximately 1.3 Kb in all luteal tissue
samples. Muscle tissue, which served as a source of negative control RNA, was devoid of any corresponding band
(not shown). There was a large amount of variability
www.reproduction-online.org
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Figure 1 Northern analysis of Ii mRNA in bovine luteal tissue.
(A) Northern blot showing Ii mRNA in a single CL collected from
each of the following times of the estrous cycle: early (day 5, n ¼ 6);
during midcycle (days 10–12, n ¼ 6); or late (day 18, n ¼ 6); and at
0 (n ¼ 5), 0.5 (n ¼ 5), 1 (n ¼ 5), 4 (n ¼ 5), 12 (n ¼ 4) or 24 h (n ¼ 5)
following administration of 25 mg PGF2a to the cow. 18S rRNA corresponding to each sample is also shown. (B) Steady-state concentration of Ii mRNA in luteal tissues collected at each time point
(mean^S.E.M. , n values are as stated above). Bars represent densitometric values of Ii mRNA standardized to 18S rRNA. Values with
different letters are significantly different (P , 0.05).

among animals in the steady-state concentration of Ii
mRNA following in vivo administration of PGF2a. This is
responsible for the apparent discrepancy between the density of bands in the Northern blot shown in Fig. 1A and
the graph shown in Fig. 1B, which represents the mean of
data from four or five animals at each time after PGF2a
administration. There were no differences in concentrations of Ii mRNA between CL collected at any stage of
the estrous cycle; however there was a greater than
two-fold increase in steady-state concentrations of Ii
mRNA in CL collected 24 h after PGF2a administration
(P , 0.05, Fig. 1B). Figure 2A shows a Northern blot of
DMa mRNA demonstrating the presence of a single DMa
transcript in luteal tissue. Muscle tissue RNA was devoid
of any corresponding band (not shown). Similar to the
results of Ii Northern analysis, a large amount of variability
among animals was also found in DMa mRNA concentrations following PGF2a administration, which is responsible for the apparent difference between the density of
bands in the Northern blot shown in Fig. 2A and the
graph shown in Fig. 2B, which represents the mean of
data from four or five animals at each time after PGF2a
administration. Such variability was not observed among
animals in CL collected during the estrous cycle. Concentrations of DMa mRNA tended (P . 0.08) to be greater in
CL collected during midcycle compared with CL collected
early (day 5) or late (day 18) in the estrous cycle (Fig. 2B).
There were no differences (P . 0.10) in concentrations of
Reproduction (2006) 131 689–698
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Figure 2 Northern analysis of DMa mRNA in bovine luteal tissue.
(A) Northern blot showing DMa mRNA in a single CL collected from
each of the following times of the estrous cycle: early (day 5, n ¼ 6);
during midcycle (days 10–12, n ¼ 6); or late (day 18, n ¼ 6); and at
0 (n ¼ 5), 0.5 (n ¼ 5), 1 (n ¼ 5), 4 (n ¼ 5), 12 (n ¼ 4) or 24 h (n ¼ 5)
following administration of 25 mg PGF2a to the cow. 18S rRNA corresponding to each sample is also shown. (B) Steady-state concentrations of DMa mRNA in luteal tissues collected at each time point
(mean^S.E.M. , n values are as stated above). Bars represent densitometric values of DMa mRNA standardized to 18S rRNA. Values with
different letters tended to be significantly different (P , 0.08).

Figure 3 Northern analysis of DMb mRNA in bovine luteal tissue.
(A) Northern blot showing DMb mRNA in a single CL collected from
each of the following times of the estrous cycle: early (day 5, n ¼ 6);
during midcycle (days 10–12, n ¼ 6); or late (day 18, n ¼ 6); and at
0 (n ¼ 5), 0.5 (n ¼ 5), 1 (n ¼ 5), 4 (n ¼ 5), 12 (n ¼ 4) or 24 h (n ¼ 5)
following administration of 25 mg PGF2a to the cow. 18S rRNA corresponding to each sample is also shown. (B) Steady-state concentrations of DMb mRNA in luteal tissues collected at each time point
(mean^S.E.M. , n values are as stated above). Bars represent densitometric values of DMa mRNA standardized to 18S rRNA. Values with
different letters are significantly different (P , 0.05).

DMa mRNA in CL collected following administration of a
luteolytic dose of PGF2a, possibly due to the large degree
of animal-to-animal variation mentioned earlier. Messenger RNA encoding DMb was also detected in luteal tissue
by Northern analysis, as demonstrated by the presence of
a single DMb transcript in all luteal tissue samples
(Fig. 3A). Muscle tissue RNA was also devoid of any band
corresponding to DMb (not shown). Concentrations of
DMb mRNA were greater (P , 0.05) in midcycle CL as
compared with CL collected early or late in the estrous
cycle (Fig. 3B), similar to DMa. There were no differences
in concentrations of DMb mRNA following PGF2a
administration.
Steady-state concentrations of DMa and DMb mRNA in
CLENDO cells and mixed luteal cells were compared in
order to determine whether endothelial cells derived from
the bovine corpus luteum expressed DMa and DMb.
Purity and composition of the CLENDO cell cultures and
mixed luteal cell cultures was assessed using quantitative
RT-PCR to determine steady-state concentrations of mRNA
encoding CD31 and StAR protein. CD31 mRNA was present both in mixed luteal cell and CLENDO cultures, with
much greater steady-state concentrations present in
CLENDO cultures. StAR mRNA, while abundant in mixed
luteal cell cultures, was undetectable in some CLENDO
cultures, and was present in concentrations near the
detection limit of the PCR assay in others (data not
shown). Messenger RNA encoding DMa and DMb was

detectable in cultures of mixed luteal cells as well as
CLENDO cell cultures. Steady-state concentrations of
DMa, but not DMb, mRNA were greater in CLENDO
cultures (Fig. 4).
The effects of LH, PGF2a and TNF-a on the concentrations of DMa mRNA in cultured bovine luteal cells are
displayed in Fig. 5. Concentrations of DMa were less in
TNF-a-treated
cultures
compared
with
controls
(P , 0.05). Similarly, in the presence of LH or PGF2a,
TNFa caused a reduction in DMa mRNA concentrations.
Treatment with TNF-a in the presence of both LH and
PGF2a also caused slight, but non-significant, reductions
in DMa mRNA. LH, PGF2a and TNF-a were all without
effect on concentrations of BoLA-DMb mRNA in cultured
luteal cells (Fig. 5).

Reproduction (2006) 131 689–698

Discussion
The present study is the first to demonstrate the presence
of mRNA encoding Ii, DMa and DMb in the CL of any
species. These results are significant when considering the
increase in the ability of luteal cells to stimulate T cell
proliferation in response to PGF2a. Although we have previously demonstrated that reduction in progesterone synthesis is at least partly responsible for the increase in the
ability of luteal cells to stimulate T lymphocyte proliferation following PGF2a administration (Cannon et al.
2003), alteration in intracellular antigen processing could
www.reproduction-online.org
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Figure 4 Steady-state concentrations of DMa and DMb mRNA in cultures of mixed luteal cells and CLENDO cells. Bars represent concentrations of DMa and DMb mRNA, as determined by RT-qPCR, in
RNA extracted from cultures of mixed luteal cells (gray bars) or luteal
endothelial cells (black bars) (mean^S.E.M. , n ¼ 3). *Significant
difference between mixed luteal cell and luteal endothelial cell
cultures.

Figure 5 Steady-state concentrations of DMa mRNA (upper panel)
and DMb mRNA (lower panel) in cultures of mixed luteal cells. Bars
represent concentrations of DMa and DMb mRNA, as determined by
RT-qPCR, in RNA extracted from luteal cells cultured in the presence
or absence of LH and/or PGF2a, with (hatched bars) or without (black
bars) TNF-a. Different letters denote significant differences between
cultures in the presence or absence of TNF-a (mean^S.E.M. , n ¼ 4,
P , 0.05).
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also contribute to the enhanced ability of luteal cells from
regressing CL to stimulate T cell proliferation. Alterations
in DMa and DMb expression near the end of the estrous
cycle could catalyze a change in luteal cells that facilitates the process of luteal regression.
Steady-state concentrations of Ii mRNA were not different at any stage of the estrous cycle. The reason for this is
not clear. Class II MHC expression on bovine luteal cells
increases throughout the estrous cycle and following
PGF2a administration (Benyo et al. 1991), and since Ii is
required for transport of class II MHC molecules to the
cell surface, expression of Ii would be expected to parallel
class II MHC expression. Given the observed lack of
change in Ii mRNA during the estrous cycle or following
administration of PGF2a, it appears that this gene is constitutively expressed in luteal tissue. It is possible that constitutive expression of Ii is sufficient to allow transport of
class II MHC molecules to the cell surface. It must be
noted, however, that the present study measured mRNA
whereas the previous study measured cell surface proteins
(Benyo et al. 1991). In that study, expression of class II
MHC molecules by luteal cells was not measured beyond
12 h after a luteolytic dose of PGF2a. It is possible that
class II MHC expression may increase dramatically by
24 h after PGF2a, similar to the increase in Ii mRNA concentrations observed in the present study.
Concentrations of DMa and DMb mRNA were greatest
in the CL during midcycle, and declined near the time of
luteal regression. Since previous studies have shown that
Ii and DM are coordinately regulated by the class II transactivating factor CIITA (Steimle et al. 1994, Chang & Flavell 1995), this result was unexpected in light of the
observed lack of change in Ii mRNA concentration
throughout the estrous cycle. The number of bovine luteal
cells expressing class II MHC molecules, as well as the
degree of class II MHC expression, both increase near the
time of luteal regression (Benyo et al. 1991). The decline
in DMa and DMb mRNA concentrations in luteal tissue
concurrent with increases in class II MHC expression may
result in presentation of a repertoire of peptides to T cells
during luteal regression that is different from that presented during midcycle. Administration of a luteolytic
dose of PGF2a to the cow did not induce changes in the
steady-state concentrations of DMa or DMb mRNA. The
reason for the lack of effect of PGF2a on DMa and DMb
expression is unknown, but it is evident that the control of
expression of these genes in the CL is not regulated by
PGF2a. Treatment of cultured luteal cells with TNF-a
reduced concentrations of DMa, and elevation of TNF-a
during luteal regression has been demonstrated (Ji et al.
1991, Shaw & Britt 1995). Elevation of TNF-a in the CL
was not observed until after the decline in circulating and
tissue concentrations of progesterone, but intra-luteal concentrations of TNF-a may increase prior to the decline in
circulating concentrations of progesterone, which would
explain the decline in DMa mRNA observed in late cycle
CL. Steady-state concentrations of DMb mRNA were not
Reproduction (2006) 131 689–698
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affected by LH, TNF-a or PGF2a, indicating that multiple
factors control the expression of DM in the CL.
The present study demonstrates the presence of Ii, DMa
and DMb mRNA in luteal tissue in amounts detectable
using the relatively non-sensitive method of Northern analysis. That these messages are detectable by Northern analysis is suggestive of a source of mRNA other than
infiltrating macrophages and B lymphocytes, which are
relatively few in number compared with the total number
of cells in the bovine CL. DMa and DMb mRNA were
also found in CLENDO cultures in the present study,
which provides support for the hypothesis that a cell type
in addition to macrophages in the CL expresses these
components of the antigen-processing pathway. It is worth
noting that the CLENDO cultures used in the present
study are composed of very highly purified populations of
luteal endothelial cells, since the concentration of
CD31 mRNA in CLENDO cells was approximately tenfold greater than in mixed luteal cell cultures, whereas
StAR mRNA is almost undetectable. Conversely, the
mixed luteal cell cultures contain largely steroidogenic
cells, but are likely to also contain small numbers of
endothelial cells; large amounts of StAR mRNA were present in the mixed luteal cell cultures, whereas concentrations of CD31 mRNA were much less than those in
CLENDO cultures. Steady-state concentrations of DMa
were greater in CLENDO cell cultures compared with
mixed luteal cell cultures, and although it was not significant, concentrations of DMb mRNA also appeared to be
greater in CLENDO cell cultures compared with mixed
luteal cell cultures. However, DMa and DMb mRNAs
were also present in mixed luteal cell cultures in relatively
high abundance. From the analysis of CD31 concentrations in the CLENDO and mixed luteal cell cultures, we
have concluded that endothelial cells make up a very
small proportion of the total cells in mixed luteal cell cultures. Therefore, it seems unlikely that endothelial cells
account for the relatively large amount of DMa and DMb
mRNA present in mixed luteal cell cultures. We have not
assessed the presence of macrophages in these cultures,
but while it is unlikely that macrophages are present in
the CLENDO cultures, due to the purification procedures
used to derive these cultures, it is possible that significant
numbers of macrophages are present in mixed luteal cell
cultures. This would account for the presence of the relatively large amount of DMa and DMb mRNA found in
mixed luteal cell cultures. It is unfortunate that it was not
possible to obtain a pure population of steroidogenic
luteal cells for these studies, and it is not possible to conclude from this experiment whether or not steroidogenic
cells express DMa and DMb. However, these results
clearly demonstrate that luteal endothelial cells express
DMa and DMb.
In conclusion, the present study demonstrates the
expression of Ii, DMa and DMb genes in luteal tissue.
These genes encode intracellular antigen-processing
proteins required for processing and presentation of
Reproduction (2006) 131 689–698

antigenic peptides to T lymphocytes. The changes in DMa
and DMb expression observed near the end of the estrous
cycle could result in presentation of an altered repertoire
of self-peptides in the context of class II MHC molecules.
This alteration of antigen presentation may have significant implications for regulation of luteal function via interaction of resident T lymphocytes with cells of the CL.
However, since expression of the antigen-processing components examined in this study is greatest during midcycle, it is possible that presentation of antigen by class II
MHC is necessary in the fully functional CL to maintain a
state of immune tolerance to the tissue. Since immune tolerance would no longer be essential at the end of the
estrous cycle, the decline in DMa and DMb expression
may serve to facilitate activation of immune cells that may
participate in the process of regression. Future studies are
needed to determine the role(s) played by the immune system in regulation of luteal function.
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